Vitamin D in adults with new ITP
Part of Blood & lymphatic clinical trials.
This trial looks at vitamin D levels in adults who have just been diagnosed with immune thrombocytopenia (ITP) and have received their first steroid treatment. It aims to see if vitamin D is linked to ITP severity or recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with primary ITP (your low platelets are not caused by another condition).
- You have received first-line steroid therapy for ITP.
- You do not have secondary ITP (ITP caused by another illness).
- You do not have long-term kidney or liver disease.
- You do not have malnutrition or a condition that prevents absorbing nutrients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and immune system patterns in adults with primary immune thrombocytopenia (ITP) who are starting their first treatment. The goal is to better understand what’s happening in ITP, which may improve how future patients are cared for.
This study compares two intravenous (IV) IgG treatment regimens for children newly diagnosed with immune thrombocytopenia (ITP). It aims to find a regimen that works well and is safe for raising low platelet counts.
This trial tests how many cycles of high-dose dexamethasone (a steroid) work best for adults newly diagnosed with ITP, a condition that causes low platelets and bruising or bleeding. The goal is to find the right dose schedule to safely raise platelet counts.
This study looks at what patients with ITP prefer in their treatments. It may help doctors understand which treatment options matter most to patients like you.
This trial tests a combination of upadacitinib (a pill that calms the immune system) and high-dose dexamethasone (a steroid) as the first treatment for adults with newly diagnosed immune thrombocytopenia (ITP). It aims to see if this mix can safely raise platelet counts better than steroids alone.
This trial studies a short, high-dose steroid plan (prednisone plus dexamethasone) to treat immune thrombocytopenia (ITP) in children and raise low platelet counts. It may help reduce bleeding risk while using an approach tested in children soon after diagnosis.
Hear when a new Vitamin D Concentration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.